Impact of Multisite artery disease on Clinical Outcomes After Percutaneous Coronary Intervention: An Analysis from the e-Ultimaster Registry.
Ofer KoboMajdi SaadaClemens von BirgelenPim A L ToninoAndres Íñiguez-RomoOle FröbertMajdi HalabiRohit M OemrawsinghJawed PoladAlexander J J IJsselmuidenMarco RoffiAdel AminianMamas A MamasAriel RoguinPublished in: European heart journal. Quality of care & clinical outcomes (2022)
Patients with previously known vascular disease experienced an increased risk for adverse cardiovascular events and mortality post percutaneous coronary intervention. This risk is highest among patients with multisite artery disease.Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02188355.
Keyphrases
- cardiovascular events
- percutaneous coronary intervention
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- cardiovascular disease
- antiplatelet therapy
- clinical trial
- randomized controlled trial
- study protocol
- heart failure
- atrial fibrillation
- risk factors
- coronary artery bypass
- adverse drug